ARTA
IOVA icon

A.R.T. Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

A.R.T. Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-106,184
Closed -$1.01M – 1487
2019
Q1 		$1.01M Buy
+106,184
New +$1.03M 0.06% 479
2018
Q4 		– Sell
-85,082
Closed -$957K – 1483
2018
Q3 		$957K Buy
85,082
+27,181
+47% +$386K 0.04% 597
2018
Q2 		$741K Sell
57,901
-75,096
-56% -$1.1M 0.03% 768
2018
Q1 		$2.25M Buy
+132,997
New +$2.01M 0.09% 333
2015
Q2 		– Sell
-25,549
Closed -$309K – 1579
2015
Q1 		$309K Buy
+25,549
New +$288K 0.01% 1102

Other funds holding IOVA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return